Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies. - sprookjes - yvandenbroek - TriplyDB

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

http://www.wikidata.org/entity/Q33797609

about

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data.Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions.Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.Antithrombotic Therapy for ACS in Elderly Patients.Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets.Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention.

P2860

Q31125799-4225D9F0-F87C-44DA-92F3-321CEFDEBEB3 Q38037672-333A75F6-A2C2-477D-B284-12A65D2A8803 Q38545163-E62A66D5-30F0-42C1-9AF8-7032714386D5 Q39598850-279D090B-F627-4A8D-9E1A-26039A1344E3 Q39766399-EA369C62-8806-464D-9EB5-A9E66327457E Q47632915-63D3A694-5BD7-4120-AF31-D3E664F8C80A Q48512017-D5F43EB3-EC25-4D7B-82EE-0184990F9E8A Q51704347-5AE978B2-4792-498F-955A-5ACDAA2F72B5

P2860

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

http://www.wikidata.org/entity/Q33797609

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@ast

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@en

type

label

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@ast

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@en

prefLabel

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@ast

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@en

P1433

Q33797609-ED25DBA3-80E9-4C60-B529-820DF5B8A0FF

P1476

Q33797609-AC7943C1-FEDA-42CB-9BD5-03DDBE89B4C9

P2093

Q33797609-2B4BEA0B-E16F-4F28-B140-81106CD526AC

P2860

Q33797609-036BF095-969E-4F54-8D2C-03767239ACA7

Q33797609-089F7D0E-9094-477F-BA0B-8300C3110DA3

Q33797609-0D47A207-5C80-4EB4-BED0-CE9945BF6AFD

Q33797609-135F3D30-6C61-4C8D-8BB9-8D3AFFFC0AD7

Q33797609-15DD0271-ED33-4E34-A13D-1316C14EF3FC

Q33797609-23379DAE-BA48-4CE3-98CF-8E3FF41F5553

Q33797609-235B773D-7344-4DA2-893E-CD10D570A4EE

Q33797609-247EE8D6-CB37-416C-932C-F34ED66027FC

Q33797609-34CF03A1-1B73-466F-BAD3-6FB4E083630E

Q33797609-362700DD-89D3-49B5-BEE7-49B43E2A863A

P304

Q33797609-0F3E7EE0-3E0B-4741-9B31-31D9382A6F63

P31

Q33797609-873E1176-027C-4064-9773-CD3C31BDDC4B

P356

Q33797609-21E91270-F41D-4C2E-9DBB-7F1F1D0B55F1

P407

Q33797609-62014B15-E89B-454E-989B-3D2BDCB4D2DC

P478

Q33797609-D6D36BE4-66F8-4489-A125-DE978C72DD3A

P577

Q33797609-E27458A3-F88D-4127-91AF-AC62565E064A

P698

Q33797609-571AA5A3-9714-4D54-AE53-32154418845E

P932

Q33797609-61996033-3A1B-4DDF-97DB-81657A31219B

P356

P1433

Vascular Health and Risk Management

P1476

Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.

@en

P2093

François Schiele

http://www.w3.org/2001/XMLSchema#string

P2860

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

Contaminated heparin associated with adverse clinical events and activation of the contact system

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

Bivalirudin for patients with acute coronary syndromes

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Bivalirudin during primary PCI in acute myocardial infarction

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Synthesis of thrombin-inhibiting heparin mimetics without side effects.

Recombinant activated factor VII in patients at high risk of bleeding.

P304

179-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S6099

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20407625

http://www.w3.org/2001/XMLSchema#string

P932

2856573

http://www.w3.org/2001/XMLSchema#string